Fluorescence was detected using FLUOstar Omega (BMG LABTECH, Aylesbury, United Kingdom) and the results were normalized by protein concentration in each well through a micro-bicinchoninic acid (BCA
However, the largest 24-week trial with 536 participants failed to show statistically significant weight loss, which led to development termination
For more severe cases or when systemic inflammation is significant, combining both provides broader coverage
A 26-week course of 60 mg twice daily led to a 69% relative reduction in the rate of percent predicted FVC decline versus placebo (treatment difference 2.9%
In trials where semaglutide tablets was added on to metformin and/or sulfonylurea, basal insulin alone, or metformin in combination with basal insulin in patients with moderate renal impairment, severe hypoglycemia was not reported in any of the patients in the trial
2013;8:e70833 25